Repligen Corporation RGEN
$133.33
▼ -2.06% 24H
About
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems to support the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Headquartered in Waltham, Massachusetts, it serves …
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Instruments & Supplies
CountryUnited States
Employees1,778
TickerRGEN
Statistics
Market Cap$7.52B
Revenue (TTM)$738.3M
Net Income$48.9M
Net Margin6.6%
EPS$0.86
P/E143.51
P/S9.65
P/B3.50
EV/EBITDA54.15
ROE2.5%
Dividend Yield—
Price$133.33
Data: Twelve Data · Revenue = mcap / P/S